Artificial intelligence (AI) based on machine learning offers opportunities for the life sciences. However, problems often ...

This article presents a roadmap for mastering data’s lifecycle, framed around three key pillars: (1) minimization, (2) ...

Merck to discontinue phase 3 KeyVibe-003 & KeyVibe-007 trials of vibostolimab and favezelimab FDCs with pembrolizumab in certain patients with NSCLC: Rahway, New Jersey Wednesday, ...

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Phase 3 FLASH2 Trial of HyBryte in CTCL is Underway On December 16, ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of data from ...

Abstracts presented Saturday at the American Society of Hematology in San Diego, California included studies on access to ...

Is there really science to obsessively monitoring our periods? - From aligning your period to your workouts and diet, to your ...

(RTTNews) - Achieve Life Sciences Inc. (ACHV), a late-stage pharmaceutical company, today, announced a successful End-of-Phase 2 meeting with the FDA to advance Cytisinicline as a potential first ...

Achieve Life ... completed Phase 2 ORCA-V1 trial, would be acceptable for a vaping cessation indication as an sNDA. Additionally, the FDA agreed that the company’s safety exposure data from ...

We're exploring the biochemical foundations of life. Without understanding how things work, we can’t fix them when they’re broken. In this day of modern diseases, this is critical. Fundamental science ...

We're nearing the end of Phase 5 of the MCU which marks ... and her SHIELD boss Nick Fury. Earnest science guy Bruce Banner has a life-changing experience in the lab and becomes a confused ...

Equipment makers such as Sweden-based Ericsson are banking upon increased data consumption and demand for differentiated experiences by premium users to drive the next capital expenditure cycle from ...